OTC · PLSI
Phoenix Life Sciences International Limited
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Down-$0.82 (-99.99%)
Updated Aug 16, 2026, 9:55 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 365.91K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 990
- Avg. volume
- 16
Price performance
PLSI price history
1M range · 0 trading sessions · Daily adjusted prices
PLSI does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest PLSI news
The latest Smart Investors Daily articles mentioning PLSI.
Stock researchCompany · Overview
PLSI research
Overview
Company profile and research snapshot.
Company profile
Phoenix Life Sciences International Limited operates as a healthcare solutions company in the United States and internationally. The company focuses on advancing research, integrating programs, and manufacturing of products that target and treat diabetes, pain, and cancers, as well as address psychological, gastrointestinal, autoimmune, neurological, and sleep disorders. It offers oral soft gel capsules, thin film dissolvable strips, transdermal patches, sublingual oral sprays, suppositories, and topical creams. The company was formerly known as Stem Bioscience, Inc. and changed its name to Phoenix Life Sciences International Limited in May 2018. Phoenix Life Sciences International Limited was incorporated in 2009 and is headquartered in Las Vegas Nevada.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
